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Dyslipidemia and reference values for
fasting plasma lipid concentrations in
Danish/North-European White children
and adolescents
Tenna Ruest Haarmark Nielsen1,2*, Ulrik Lausten-Thomsen1,3, Cilius Esmann Fonvig1,2,4, Christine Bøjsøe1,2,
Lise Pedersen5, Palle Skov Bratholm5, Torben Hansen2, Oluf Pedersen2 and Jens-Christian Holm1,2,3
Abstract
Background: Dyslipidemia is reported in 27 − 43% of children and adolescents with overweight/obesity and tracks
into adulthood, increasing the risk of cardiovascular morbidity. Cut-off values for fasting plasma lipid concentrations
are typically set at fixed levels throughout childhood. The objective of this cross-sectional study was to generate
fasting plasma lipid references for a Danish/North-European White population-based cohort of children and adolescents,
and investigate the prevalence of dyslipidemia in this cohort as well as in a cohort with overweight/obesity.
Methods: A population-based cohort of 2141 (1275 girls) children and adolescents aged 6 − 19 (median 11.5) years was
recruited from 11 municipalities in Denmark. Additionally, a cohort of children and adolescents of 1421 (774 girls) with
overweight/obesity aged 6 − 19 years (median 11.8) was recruited for the study. Height, weight, and fasting plasma lipid
concentrations were measured on all participants. Smoothed reference curves and percentiles were generated using the
Generalized Additive Models for Location Scale and Shape package in the statistical software R.
Results: In the population-based cohort, plasma concentrations of total cholesterol (TC) (P < 0.05), low-density lipoprotein
cholesterol (LDL) (P < 0.005), and high-density lipoprotein cholesterol (HDL) (P < 0.005) were higher in the youngest
compared to the oldest tertile. Fasting plasma levels of triglycerides (TG) (P < 0.005) increased with age in both sexes. In
boys, non-HDL was lower in the oldest compared to the youngest tertile (P < 0.0005).
Concentrations of TC, LDL, non-HDL, and TG were higher (P < 0.05), and HDL lower (P < 0.05) in the cohort with overweight/
obesity in both sexes and for all ages except for TC in the youngest girls. The overall prevalence of dyslipidemia was 6.4% in
the population-based cohort and 28.0% in the cohort with overweight/obesity. The odds ratio for exhibiting dyslipidemia in
the cohort with overweight/obesity compared with the population-based cohort was 6.2 (95% CI: 4.9 − 8.1, P < 2*10−16).
Conclusion: Fasting plasma lipid concentrations change during childhood and adolescence and differ with sex and age.
Children and adolescents with obesity have increased concentrations of circulating lipids and exhibit an increased prevalence
of dyslipidemia.
Trial registration: The study is part of The Danish Childhood Obesity Biobank; ClinicalTrials.gov ID-no.: NCT00928473
retrospectively registered on June 25th 2009.
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Background
Cardiovascular disease (CVD) is still the major cause of
mortality in the world [1]. Elevated concentrations of
circulating total cholesterol (TC), low-density lipopro-
tein (LDL), non-high-density lipoprotein (non-HDL),
and triglycerides (TG), and reduced HDL, in addition to
other well known risk factors such as obesity, smoking,
diabetes, and hypertension, are associated with the de-
velopment of atherosclerotic disease [2–5]. Elevated lipid
concentrations during childhood track into adulthood
and increase the risk of CVD, and thus morbidity and
mortality [6–9]. Similarly, obesity tracks into adulthood
[10, 11], and is positively associated with dyslipidemia
[12, 13]. Up to 27% of Danish [13] and 43% of American
children and adolescents [14] with overweight/obesity
exhibit dyslipidemia, and early treatment and prevention
is required [2].
The American Academy of Pediatrics currently recom-
mends that children with obesity or familial aggregation
of hyperlipidemia should have their lipid concentrations
monitored regularly [15]. Consistent with the increased
prevalence of obesity in childhood [16–19], the propor-
tion of children who require screening for dyslipidemia,
is increasing.
A prerequisite for the correct identification of dyslipid-
emia in children and adolescents is the definition of
normal ranges of circulating lipid concentrations. Lipid
concentrations differ with age, sex, and ethnicity [15],
and accordingly age and sex specific reference values
from each region/ethnicity is warranted. Current cut-offs
for dyslipidemia in children and adolescents are based
on data from the North American National Cholesterol
Education Program [15]. Based on these cut-offs, 20% of
American adolescents exhibit dyslipidemia [20]. A recent
European study found similar prevalence of childhood
dyslipidemia in a German cohort [21].
The present study aims to identify fasting plasma lipid
concentrations from a population-based cohort of
Danish/North-European White children and adoles-
cents, and from a normal weight subgroup of this
cohort. In addition, the study aims to explore any differ-
ences in fasting plasma lipid concentrations between the
population-based cohort and children and adolescents
with overweight/obesity.
Methods
Study populations
From October 2010 until February 2015, a population-
based cohort of children and adolescents from schools
across 11 municipalities in Denmark were phenotyped
(N = 2836). This population-based cohort was extended
with children 6 − 9 years of age recruited from March
2015 until March 2016 via the public dentistry and health
care nurses in one of these municipalities (N = 189).
Phenotyping was performed by trained medical staff
and involved an extensive questionnaire, a clinical exam-
ination, including height and weight, and a fasting blood
sample. The questionnaire was completed at home
before the examination.
Exclusion criteria for this study were 1) no blood sam-
ples available (N = 112), 2) missing data on lipid concen-
trations (N = 235), 3) more than 30 days between blood
sampling and height and weight measurements (N = 10),
4) ethnicity other than Danish/North-European White
(N = 470), 5) known familial hypercholesterolemia
(N = 0), 6) use of cholesterol-lowering medications
(N = 0), and 7) age younger than 6 years or older than
19 years (N = 57), leaving 2141 participants for further
analyses (Fig. 1).
From the population-based cohort, a normal weight
subgroup of 1639 (971 girls) children and adolescents
was defined by a body mass index (BMI) ≤ 90th and
≥10th percentile for age and sex according to Danish
references [22].
From The Children’s Obesity Clinic (TCOC), Depart-
ment of Pediatrics, Copenhagen University Hospital
Holbæk, 1759 children and adolescents with a BMI
above the 90th percentile [22] were included in the study
from 2008 until December 2015 (the TCOC cohort).
These participants had fasting blood samples collected
within 30 days of the measurements of height and
weight. Exclusion criteria for the present study were 1)
ethnicity other than Danish/North-European White
(N = 248), 2) known genetic causes of obesity (N = 16),
3) known familial hypercholesterolemia (N = 4), 4) use
of lipid-lowering medication (N = 0), and 5) age younger
than 6 years or older than 19 years (N = 70). This left
1421 children and adolescents with overweight/obesity
for further analyses.
Anthropometrics
Height was measured by stadiometer to the nearest
1 mm. Weight was measured to the nearest 100 g on a
Tanita® BC418 scale (Tanita Corp., Tokyo, Japan) in the
population-based cohort, and on a Tanita® Digital
Medical Scale, WB-110 MA (Tanita Corp., Tokyo, Japan)
in the TCOC cohort. Measurements were performed
wearing light indoor clothes and without shoes. BMI
was calculated as weight divided by height in meters
squared. The LMS method [23], which uses the median
(M), the coefficient of variation (S), and a measure of the
skewness (L) in a Box-Cox transformation to normalize
the data, was used to calculate the BMI standard deviation
scores (SDS) according to Danish references [22].
Puberty
In the population-based cohort, the pubertal developmen-
tal stage according to the Tanner classification [24, 25]
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was self-evaluated using a descriptive text and color charts
for picture pattern recognition. In the TCOC cohort, a
pediatrician evaluated the pubertal developmental stage at
the first visit to the clinic. Self-evaluated pubertal staging
has been shown to adequately describe pre-pubertal
versus pubertal status [26]. Therefore, pubertal stage
in both the population-based cohort and the TCOC
cohort were defined as pre-pubertal (Tanner 1) or
pubertal (Tanner 2-5).
Blood samples
After an overnight fast, venous blood samples were
drawn between 7 and 9 AM, processed within 1 h, and
analyzed within 6 − 8 h after sampling at the Depart-
ment of Clinical Biochemistry, Copenhagen University
Hospital Holbæk. Analyses were, until May 15th 2013,
performed on a Cobas® 6000 (Roche Diagnostics, Mann-
heim, Germany) (Npopulation-based = 699, NTCOC = 952)
and, from May 16th onwards, on a Dimension
Vista®1500 (Siemens Healthcare, Erlangen, Germany)
(Npopulation-based = 1442, NTCOC = 469) using enzymatic
colorimetric method.
Detection limits on the Cobas® 6000 were 0.1 mmol/L
for TG and TC, and 0.08 mmol/L for HDL, and on the
Dimension Vista®1500, 0.02 mmol/L for TG, 1.29 mmol/
L for TC, and 0.05 mmol/L for HDL according to the
manufacturer. Internal quality control provided intra-
assay coefficients of variations with the following frac-
tions of 0.010 − 0.026 for TC, 0.008 − 0.034 for HDL,
and 0.009 − 0.024 for TG on the Cobas® 6000, and of
0.014 − 0.028 for TC, 0.027 − 0.043 for HDL, and
0.010 − 0.020 for TG on the Dimension Vista®1500.
To ensure comparability of TC, HDL, and TG concen-
trations measured on the Cobas® 6000 and Dimension
Vista®1500, routine laboratory data from 2012 and 2014
were extracted from the laboratory information system
in order to compare the two analyzers. Only data from
adults (age 18 – 99 years) were included (Cobas, 2012:
N = 37,222/34,744/31,615 and Dimension Vista, 2014:
N = 33,126/34,436/36,980 for TC/HDL/TG, respect-
ively). Extreme values, defined as over/under the mean
+/− 1.5*inter-quartile range, were excluded (Cobas,
2012: N = 1404/1749/2343 and Dimension Vista, 2014:
N = 1262/1801/2600) (Additional file 1: Table S1). The
mean of TC concentrations was 0.26 mmol/L and of
HDL 0.06 mmol/L lower when measured on the Dimen-
sion Vista®1500 compared to the Cobas® 6000. The mean
of triglyceride concentrations was 0.08 mmol/L higher
on the Dimension Vista®1500 compared to the Cobas®
6000, with a tendency to a slight increase in the difference
in higher concentrations (Additional files 2, 3 and 4:
Figures S1–S3). To account for these differences in meas-
urement methods, in the present study, TC and HDL
concentrations measured with the Cobas® 6000 were
deducted by 0.26 and 0.06 mmol/L, respectively. TG con-
centrations measured on Cobas® 6000 were multiplied by
1.17 and deducted by 0.16 mmol/L. The Friedewald For-
mula was used to calculate the LDL concentration [27].
Non-HDL was calculated as TC − HDL.
Dyslipidemia
Dyslipidemia was defined according to the American Heart
Associations classification corresponding to the 95th per-
centile in a American population as total cholesterol
>5.2 mmol/L (200 mg/dl), LDL > 3.4 mmol/L (130 mg/dl),
HDL <0.9 mmol/L (35 mg/dl), or triglycerides >1.7 mmol/
L (150 mg/dl), or a combination thereof [3].
Statistical methods
All statistical calculations were performed using the stat-
istical software R (version 3.2.4) [28]. The Wilcoxon
signed rank test was used to determine differences
between sexes in the descriptive statistics. Thereafter, all
analyses were performed stratified by sex. Percentiles
Fig. 1 Age distribution. Number of children and adolescents within each age group in the population-based cohort generating the fasting plasma lipid
reference intervals. a Girls. b Boys
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and smoothed percentile curves were generated using
the Generalized Additive Models for Location Scale and
Shape (gamlss) package [29] with the penalized cubic
spline function and the Box-Cox t-distribution family or
the Box-Cox Power Exponential distribution family (best
fit determined by the Akaike Information Criterion). The
models were tested using qq-plots and worm-plots. The ef-
fects of puberty were investigated for each sex using general-
ized linear models adjusted for BMI SDS. In the linear
regressions, concentrations of TG were logarithmically
transformed to achieve a normal distribution of residuals. Ef-
fects of age within each sex were investigated using analysis
of variance and Tukey Honest Significant Difference method
on normally distributed data, and with the Kruskal-Wallis
test and Pairwise Wilcoxon test on non-normally distributed
data, with participants grouped in tertiles according to ages
in the population-based cohort: young (corresponding to
age < 10.1 years in girls. And to age < 9.3 years in boys),
middle (corresponding to age > =10.1 and <13.8 years in
girls. And to age > =9.3 and <12.7 years in boys), and old
(corresponding to age > =13.8 years in girls. And to
age > 12.7 years in boys). Normality of data was evaluated
using histograms and qq-plots. Differences between mean
fasting lipid concentrations between cohorts within age
groups for each sex were investigated using Student’s t-test
on normally distributed data, and Wilcoxon rank sum test
on non-normally distributed data. Odds ratios (OR) were
calculated using logistic regression adjusted for age,
sex, and pubertal developmental stage.
Results
From the population-based cohort, 2141 (1275 girls) chil-
dren and adolescents with a median age of 11.5 years were
included in the study. Of these, 17.3% (N = 371) were
overweight/obese (BMI > 90th percentile) and 6.0%
(N = 128) were underweight (BMI < 10th percentile) [22].
As there were significant differences between sexes in age,
and in concentrations of TC, LDL, non-HDL, and triglyc-
erides (p < 0.05), all analyses were performed stratified by
sex. Descriptive data on the population-based cohort and
the TCOC cohort are presented in Table 1 and percentiles
for fasting plasma concentrations of TC, LDL, HDL, non-
HDL, and TG in the population-based cohort in Table 2.
The percentile curves along with the data-points from
the population-based cohort are provided in Figs. 2, 3, 4, 5
and 6. In addition, percentile curves for the TCOC cohort
are shown in the corresponding graphs (Figs. 2, 3, 4, 5 and
6). The same percentiles for the normal weight sub-
group of the population-based cohort are presented
in Additional file 5: Table S2. The corresponding cen-
tiles in the total population for the most part differed from
the normal weight subgroup on the second decimal of the
lipid concentrations; there was a tendency for a difference
on the first decimal of 0.1 in the upper centiles.
Fasting plasma total cholesterol
In girls, the TC concentrations (Fig. 2a) were 0.1 mmol/
L higher in the youngest tertile compared to the middle
tertile (95% confidence interval (CI): [0.01 − 0.22],
P = 0.03) and 0.2 mmol/L higher compared to the oldest
tertile (95% CI: [0.23 − 0.33], P = 2.3*10−6). Mean con-
centrations in girls in the TCOC cohort differed from
the population-based cohort with higher values only in
the oldest age group (P = 0.0018). In boys, the TC con-
centration (Fig. 2b) was 0.4 mmol/L lower in the oldest
tertile compared to the youngest tertile (95% CI:
[0.23 − 0.48], P < 0.00001) and 0.5 mmol/L lower com-
pared to the middle tertile (95% CI: [0.34 − 0.59],
P < 0.00001). The levels of TC in boys from the TCOC
cohort were stable and higher than in boys in the
population-based cohort in the middle and oldest age
groups (P < 0.03).
Fasting plasma LDL
In girls, the LDL concentrations (Fig. 3a) were 0.1 mmol/
L higher in the youngest population-based tertile com-
pared to the middle tertile (95% CI: [0.04 − 0.24],
P = 0.0032) and 0.2 mmol/L higher compared to the
oldest tertile (95% CI: [0.11 − 0.30], P = 2.7*10−6), but
remained stable at a higher level throughout all ages in
the TCOC cohort (P < 0.002). The concentrations of LDL
(Fig. 3b) in boys were 0.2 mmol/L higher in the youngest
tertile compared to the oldest tertile (95% CI: [0.10 − 0.32,
P = 1.8*10−5), and 0.3 mmol/L higher (95% CI:[0.15;0.37],
Table 1 Descriptive information on the population-based cohort,
and The Children’s Obesity Clinic (TCOC) cohort with overweight/
obesity
Population-based TCOC
Girls Boys Girls Boys
N 1275 866 774 647
Age, years 11.9
(6.0 − 19.0)
11.0*
(6.1 − 18.9)
11.7
(2.0 − 24.7)
11.8*
(2.8 − 21.4)
BMI SDS 0.25**
(−3.07 − 3.71)
0.26**
(−3.48 − 4.54)
2.7**
(1.4 − 6.2)
3.1**
(1.38 − 6.1)
TC mmol/L 3.9*
(2.0 − 7.5)
3.7**
(1.9 − 6.0)
3.9*
(1.7 − 6.9)
4.0**
(1.7 − 7.2)
LDL mmol/L 2.0**
(0.3 − 5.7)
1.9**
(0.6 − 4.1)
2.3**
(0.5 − 5.8)
2.3**
(0.2 − 5.2)
HDL mmol/L 1.5**
(0.6 − 2.8)
1.5**
(0.5 − 2.7)
1.1**
(0.5 − 2.3)
1.1**
(0.4 − 2.3)
Non-HDL
mmol/L
2.4**
(0.4 − 6.1)
2.3**
(0.8 − 4.8)
2.8**
(1.0 − 6.4)
2.8**
(0.6 − 6.0)
TG mmol/L 0.7**
(0.1 − 2.8)
0.5**
(0.1 − 2.9)
0.9**
(0.1 − 4.9)
0.9**
(0.1 − 4.6)
Data are medians and ranges. Lipids are fasting plasma concentrations of total
cholesterol (TC), low-density lipoprotein cholesterol (LDL), high-density lipoprotein
cholesterol (HDL), non-HDL, and triglycerides (TG). Significant P-values reflect
differences between the population-based cohort and the TCOC cohort for each
sex. *P < 0.05. **P < 0.0001
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P < 0.000001) compared to the middle tertile. The LDL
concentrations in boys from the TCOC cohort were
higher than in boys in the population-based cohort at all
ages (P < 0.0001).
Fasting plasma HDL
In girls, the HDL concentrations (Fig. 4a) in the
population-based cohort were 0.1 mmol/L lower in the
oldest tertile compared to the middle tertile (95% CI:
[0.02 − 0.12], P = 0.004) and 0.1 mmol/L lower com-
pared to the youngest tertile (95% CI: [0.04 − 0.15],
P = 4.4*10−5). In girls from the TCOC cohort, the HDL
concentrations exhibited a constantly lower level
(P < 2.2*10−16) in all three age groups. The HDL con-
centrations (Fig. 4b) in boys in the population-based
cohort in the oldest tertile were 0.2 mmol/L lower
Table 2 Percentiles for fasting plasma concentrations of TC, LDL, HDL, non-HDL, and TG in the population-based cohort
Age
(years)
Girls Boys
6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 7 8 9 10 11 12 13 14 15 16 17 18 19
TC
(mmol/L)
2.5th 2.9 2.9 2.9 2.9 2.8 2.8 2.8 2.7 2.7 2.7 2.7 2.7 2.7 2.8 2.6 2.7 2.7 2.7 2.8 2.8 2.7 2.6 2.5 2.4 2.4 2.4 2.4 2.5
5th 3.1 3.1 3.0 3.0 3.0 3.0 2.9 2.9 2.8 2.8 2.9 2.9 2.9 2.9 2.8 2.8 2.9 2.9 2.9 2.9 2.9 2.8 2.6 2.6 2.5 2.5 2.6 2.6
10th 3.3 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.0 3.0 3.0 3.1 3.1 3.1 3.0 3.0 3.1 3.1 3.1 3.1 3.1 3.0 2.8 2.8 2.7 2.7 2.7 2.8
50th 4.0 4.0 4.0 4.0 4.0 3.9 3.9 3.8 3.8 3.7 3.8 3.8 3.8 3.9 3.7 3.8 3.8 3.9 3.9 3.9 3.9 3.7 3.5 3.4 3.4 3.4 3.4 3.5
90th 5.0 5.0 5.0 4.9 4.9 4.8 4.8 4.7 4.6 4.6 4.7 4.7 4.7 4.8 4.6 4.6 4.7 4.8 4.8 4.8 4.8 4.6 4.3 4.2 4.2 4.2 4.2 4.3
95th 5.3 5.3 5.3 5.3 5.2 5.2 5.1 5.0 4.9 4.9 5.0 5.0 5.1 5.1 4.9 4.9 5.0 5.1 5.1 5.1 5.1 4.9 4.6 4.5 4.5 4.4 4.5 4.6
97.5th 5.6 5.6 5.6 5.6 5.5 5.5 5.4 5.3 5.2 5.2 5.3 5.3 5.4 5.4 5.2 5.2 5.3 5.3 5.4 5.4 5.4 5.1 4.9 4.8 4.7 4.7 4.7 4.8
LDL
(mmol/L)
2.5th 1.2 1.2 1.2 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 0.9 0.9 1.0
5th 1.3 1.3 1.3 1.3 1.3 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.1 1.1 1.1 1.0 1.0 1.1 1.1
10th 1.5 1.5 1.5 1.5 1.5 1.4 1.4 1.4 1.3 1.3 1.4 1.4 1.4 1.4 1.3 1.3 1.4 1.4 1.4 1.4 1.3 1.3 1.2 1.2 1.2 1.2 1.2 1.2
50th 2.2 2.2 2.2 2.2 2.1 2.1 2.0 2.0 1.9 1.9 2.0 2.0 2.0 2.1 2.0 2.0 2.0 2.0 2.0 2.0 2.0 1.9 1.8 1.8 1.8 1.8 1.8 1.8
90th 3.1 3.1 3.1 3.0 3.0 2.9 2.8 2.7 2.7 2.7 2.7 2.8 2.8 2.9 2.7 2.8 2.8 2.8 2.8 2.8 2.8 2.7 2.6 2.5 2.5 2.5 2.5 2.6
95th 3.4 3.4 3.4 3.3 3.3 3.2 3.1 3.0 3.0 3.0 3.0 3.1 3.1 3.2 3.0 3.0 3.1 3.1 3.1 3.1 3.0 2.9 2.8 2.7 2.7 2.7 2.8 2.8
97.5th 3.8 3.7 3.7 3.7 3.6 3.5 3.4 3.3 3.3 3.3 3.3 3.4 3.4 3.5 3.3 3.3 3.3 3.4 3.4 3.4 3.3 3.2 3.0 3.0 3.0 3.0 3.0 3.1
HDL
(mmol/L)
2.5th 1.0 1.0 1.0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 1.0 1.0 1.0 1.0 1.0 1.0 1.0 0.9 0.9 0.8 0.8 0.8 0.8 0.8
5th 1.1 1.1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.1 1.1 1.0 1.0 0.9 0.9 0.9 0.8 0.8 0.9
10th 1.2 1.2 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.2 1.2 1.2 1.2 1.2 1.1 1.1 1.0 1.0 0.9 0.9 0.9 0.9
50th 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.4 1.4 1.4 1.4 1.4 1.5 1.5 1.6 1.6 1.6 1.6 1.5 1.5 1.4 1.3 1.3 1.2 1.2 1.2
90th 2.0 2.0 2.0 2.0 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.8 1.8 1.8 2.0 2.0 2.0 2.1 2.1 2.0 2.0 1.9 1.8 1.7 1.6 1.6 1.6 1.6
95th 2.2 2.1 2.1 2.1 2.1 2.1 2.1 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.1 2.2 2.2 2.2 2.2 2.2 2.2 2.1 1.9 1.8 1.8 1.7 1.7 1.8
97.5th 2.3 2.3 2.3 2.3 2.2 2.2 2.2 2.2 2.2 2.2 2.1 2.1 2.1 2.1 2.3 2.3 2.3 2.4 2.4 2.4 2.3 2.2 2.1 2.0 1.9 1.9 1.9 1.9
Non-HDL
(mmol/L)
2.5th 1.4 1.4 1.4 1.4 1.4 1.4 1.3 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.2 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.2 1.2 1.2 1.2 1.3
5th 1.6 1.6 1.6 1.6 1.6 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.6 1.6 1.4 1.4 1.4 1.5 1.5 1.5 1.5 1.4 1.4 1.4 1.4 1.4 1.4 1.4
10th 1.8 1.8 1.8 1.8 1.8 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.8 1.8 1.6 1.6 1.6 1.6 1.7 1.7 1.6 1.6 1.6 1.6 1.5 1.5 1.6 1.6
50th 2.5 2.5 2.5 2.5 2.5 2.5 2.4 2.4 2.4 2.4 2.4 2.4 2.5 2.5 2.2 2.3 2.3 2.3 2.4 2.4 2.3 2.3 2.2 2.2 2.2 2.2 2.2 2.2
90th 3.4 3.4 3.4 3.4 3.4 3.3 3.3 3.2 3.2 3.2 3.3 3.3 3.4 3.4 3.0 3.1 3.1 3.2 3.2 3.2 3.2 3.1 3.1 3.0 3.0 3.0 3.0 3.0
95th 3.8 3.8 3.8 3.7 3.7 3.7 3.6 3.5 3.5 3.5 3.6 3.6 3.7 3.8 3.3 3.3 3.4 3.4 3.5 3.5 3.5 3.4 3.3 3.3 3.3 3.2 3.3 3.3
97.5th 4.1 4.1 4.1 4.1 4.0 4.0 3.9 3.9 3.8 3.8 3.9 4.0 4.0 4.1 3.5 3.6 3.6 3.7 3.7 3.7 3.7 3.6 3.6 3.5 3.5 3.5 3.5 3.5
TG
(mmol/L)
2.5th 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
5th 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4
10th 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4
50th 0.5 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.7 0.7 0.8 0.8 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.7
90th 0.9 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.2 1.2 1.2 1.3 1.3 1.3 0.8 0.8 0.8 0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.1 1.1 1.2 1.2
95th 1.1 1.1 1.2 1.2 1.2 1.3 1.3 1.3 1.4 1.4 1.5 1.5 1.5 1.6 0.9 1.0 1.0 1.0 1.0 1.1 1.1 1.2 1.3 1.3 1.3 1.4 1.4 1.4
97.5th 1.3 1.3 1.4 1.4 1.4 1.5 1.5 1.6 1.6 1.7 1.7 1.7 1.8 1.8 1.1 1.1 1.1 1.2 1.2 1.3 1.4 1.4 1.5 1.5 1.6 1.6 1.6 1.7
The 2.5th, 5th, 10th, 50th, 90th, 95th, and 97.5th percentile for each age group in girls and boys are presented
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compared to the youngest tertile (95% CI: [0.16 − 0.29],
P < 0.00001) and 0.2 mmol/L lower compared to the
middle tertile (95% CI:[0.18;0.31], P > 0.00001). In boys,
the HDL concentrations in the TCOC cohort were lower
than in the population-based cohort at all ages
(P < 6.0*10−15) and were significantly higher in the
youngest age group compared to the oldest age group
(95% CI: [0.17 − 0.30], P = 3.6*10−12).
Fasting plasma non-HDL
In girls, the concentration of non-HDL (Fig. 5a) did not
differ between the three age groups in the population-
based cohort (P > 0.05). In girls from the TCOC cohort,
the non-HDL concentrations exhibited a constantly
higher level in all three age groups compared to the
population-based cohort (P < 0.0001). In boys, the con-
centration of non-HDL was 0.2 mmol/L lower in the
Fig. 2 Percentile curves for concentrations of fasting plasma total cholesterol. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile curves
for TC in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s Obesity Clinic
with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of TC are in mmol/L
Fig. 3 Percentile curves for concentrations of fasting plasma low-density lipoprotein. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile
curves for LDL in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s
Obesity Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of LDL are in mmol/L
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oldest tertile compared to the middle tertile (95%
CI:[0.09;0.32], P = 0.00012). No difference was observed
between the youngest tertile and the middle or oldest
tertile (P > 0.05). Concentrations of non-HDL in boys in
the TCOC cohort were higher in all age groups
(P < 2.4*10−6).
Fasting plasma triglyceride
TG concentrations increased from the youngest to the
middle tertile in girls (P = 2.4*10−5) and boys
(P = 0.00042), and from the middle to the oldest tertile
in girls (P = 0.0011) and in boys (P = 1.8*10−5) (Fig. 6a
and b). TG concentrations in both girls and boys from
Fig. 4 Percentile curves for concentrations of fasting plasma high-density lipoprotein. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile
curves for HDL in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s
Obesity Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of HDL are in mmol/L
Fig. 5 Percentile curves for concentrations of fasting plasma non-high-density lipoprotein. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile
curves for non-HDL in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s
Obesity Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of non-HDL are in mmol/L
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the TCOC cohort were higher than in the population-
based cohort at all ages (P < 2.2*10−14). Furthermore, in
girls from the TCOC cohort, concentrations of TG were
higher in the oldest age group compared to the middle
(P = 2.0*10−5) and the youngest (P = 1.4*10−12) age
groups, and, in boys from the TCOC cohort, higher in
the oldest age group compared to the middle (P = 0.035)
and youngest age group (P = 1.1*10−9).
Puberty
Data on pubertal developmental stages were available in
77% (N = 984) of girls and in 53% (N = 463) of boys in
the population-based cohort. Pubertal girls exhibited a
0.2 mmol/L lower TC concentration compared to pre--
pubertal girls (95% CI:[−0.25; −0.06], P = 0.0013). Puber-
tal girls exhibited a 0.1 mmol/L lower LDL
concentration compared to pre-pubertal girls (95%
CI:[−0.21; −0.04], P = 0.0030). Pubertal girls exhibited a
0.1 mmol/L lower concentration of HDL compared to
pre-pubertal girls (95% CI:[−0.11; −0.02], P = 0.0028).
No difference was observed in the concentrations of
non-HDL in pubertal girls compared to pre-pubertal
girls (95% CI:[−0.14;0.04], P = 0.25). The concentration
of TG was 15% higher in pubertal girls compared to pre-
pubertal girls (95% CI:[1.08;1.22], P = 6.2*10−6).
In boys, puberty was associated with a 0.2 mmol/L
lower concentration of TC (95% CI:[−0.37; −0.11],
P = 4.2*10-4), a 0.2 mmol/L lower concentration of HDL
(95% CI:[−0.24; −0.11], P = 2.3*10-7), and a 12% higher
TG concentration (95% CI:[1.03;1.22], P = 0.0078) com-
pared to pre-puberty. No differences were observed in
the concentrations of LDL (95% CI:[−0.21;0.01],
P = 0.071) or non-HDL (95% CI:[−0.17;0.06], P = 0.34)
between pubertal and pre-pubertal boys. Adjusting for
age in the generalized linear models rendered all associa-
tions between lipid concentrations and puberty in girls
and in boys insignificant.
Similar effects of puberty were observed in the TCOC
cohort among girls as well as boys.
Dyslipidemia
The prevalence of dyslipidemia was 6.4% in the
population-based cohort, and 28.0% in the TCOC cohort
(Table 3). The odds ratio (OR) for exhibiting dyslipid-
emia was 6.2 (95% CI: 4.9 − 8.1, P < 2*10−16) in the
TCOC cohort compared to the population-based cohort.
In the population-based group, the OR for a child or
adolescent with a BMI > 90th percentile to exhibit dys-
lipidemia was 2.8 (95% CI: 1.8 − 4.4, P = 4.9*10−6) com-
pared to a child with a BMI <90th percentile, when
Fig. 6 Percentile curves for concentrations of fasting plasma triglycerides. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile curves for
TG in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s Obesity
Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of TG are in mmol/L
Table 3 Prevalence of dyslipidemia
TCOC
N (%)
Population-
based cohort
N (%)
Subgroup of normal
weight individuals
N (%)
TC > 5.2 mmol/L 101 (7.1%) 71 (3.3%) 46 (2.8%)
LDL > 3.4 mmol/L 97 (6.8%) 49 (2.3%) 33 (2.0%)
HDL < 0.9 mmol/L 180 (12.7%) 35 (1.6%) 21 (1.3%)
TG > 1.7 mmol/L 211 (14.8%) 27 (1.3%) 14 (0.8%)
One or more of
above
398 (28.0%) 137 (6.4%) 86 (5.2%)
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adjusting for age, sex, and pubertal developmental stage.
The OR for a child or adolescent from the TCOC cohort
compared to a child or adolescent from the population-
based cohort with a BMI > 90th percentile to have dys-
lipidemia was 2.9 (95% CI: 2.0 − 4.4, P = 1.0*10−7). All
ORs were driven by differences in BMI SDS, and became
insignificant when further adjusting for BMI SDS in the
models (P > 0.05).
Discussion
This study provides reference values for fasting plasma
concentrations of TC, LDL, HDL, non-HDL, and TG in
a population-based cohort of Danish/North-European
White children and adolescents. In addition, the study
evaluates the association of overweight and obesity with
these variables. We calculated the percentiles in both
the total population-based cohort and in a normal-
weight subgroup of the cohort. Excluding the individuals
with overweight/obesity in the population-based cohort
did not change the reference curves markedly other than
on the first decimal in some of the upper percentiles.
This offers no clinical relevance, since the accuracies of
the analysis methods exhibit a higher variation than the
differences in values between the total population-
based cohort and the normal-weight subgroup. We
therefore generated reference percentiles for the en-
tire population-based cohort.
Except for the concentrations of TG, the lipid concen-
trations varied more throughout childhood and adoles-
cence in boys compared to girls, with the reference
curves in boys exhibiting a biphasic pattern for TC,
LDL, HDL, and non-HDL, and a steady increase for TG.
The reference levels at the 50th and 90th percentile in
both a French cohort (N = 1976 (1004 girls), age
7 − 20 years) and a German cohort (N = 2571 (1226
girls), age 0 − 16 years), albeit showing comparable pat-
terns throughout childhood, exhibited higher concentra-
tions for TC, LDL, and TG, but similar levels of the
HDL concentrations in both sexes compared to our
study [21, 30]. Differences in overweight/obesity preva-
lences do not explain this difference, as the prevalences
of overweight and obesity in Germany, France, and
Denmark are comparable [18, 31, 32]. In addition, only
lean subjects were included in the French study [30],
and in the present study, the 50th percentile did not
change, when including the underweight, overweight,
and obese individuals from the population-based cohort.
Non-HDL concentrations among children and adoles-
cents are more indicative of persistent dyslipidemia
compared to TC, LDL, or HDL [5], and in a meta-
analysis of 233,455 adults a more potent marker of
cardiovascular risk than LDL [33]. In our study, concen-
trations of non-HDL were not affected by puberty in
either sex, and in girls not affected by age. In boys,
concentrations were lower in the oldest age group of
boys compared with the middle age group of boys. In
contrast, a study in Slovakian children and adolescents
found a negative effect of age on non-HDL in both girls
and boys [34].
Through all ages and in both sexes in the present
study, children from the TCOC cohort exhibited higher
concentrations of TC, LDL, non-HDL, and TG, and
lower concentrations of HDL than the population-based
cohort, underlining the reports from a previous study on
the effects of obesity on fasting plasma lipid concentra-
tions [13, 35]. In the German cohort, the prevalence of
dyslipidemia was similar to what is previously described
in US children and adolescents (N = 1482 (725 girls),
age 8 − 17 years) [20, 21]. The prevalence of dyslipid-
emia in our cohort was considerably lower than de-
scribed in both of these cohorts. The difference to the
German cohort may in part be explained by their inclu-
sion of a cohort with obesity from an obesity clinic,
where the degree of obesity may have been higher than
the overall degree of obesity in the population, even
though the prevalence of obesity in their cohort resem-
bled the overall German prevalence of obesity [21]. In
the present study, a higher OR for dyslipidemia was ob-
served in the TCOC cohort compared to the subgroup
with overweight/obesity from the population-based co-
hort; a difference that was correlated with differences in
BMI SDS. This indicates that differences in the degree of
obesity may influence the prevalence of dyslipidemia in
a given cohort. Similarly, the difference in prevalences of
dyslipidemia between our cohort and the American co-
hort may be explained by the difference in the preva-
lences of obesity, being higher in USA and with
increasing prevalence of extreme obesity [17–19]. In the
present study we focused on fasting concentrations of
lipids and dyslipidemia. Future studies should investigate
the distribution and effect of obesity on other cardiovas-
cular risk factors such as hypertension and insulin resist-
ance, and the possible effects – individually and
combined – of multiple risk factors present concomi-
tantly in children and adolescents.
A limitation to our study was the lack of diet registra-
tion. Nevertheless, adherence to the fasting state was as-
sured by interview on the morning of the blood
sampling. If the participant was not fasting, another
appointment for blood sampling was made.
During the study period, methods for blood sample
analysis changed at the laboratory that analyzed our
samples. This was due to hospital administrative deci-
sions not related to this study. The comparability of the
results was ensured, by applying a quality control ana-
lysis on all measurements performed at the laboratory in
2012 (Cobas® 6000) and 2014 (Dimension Vista®1500).
The variation between the Cobas® 6000 and the Dimension
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Vista®1500 in measured concentrations of HDL and TG
was less than the intra-assay variation, indicating that it
may not have been necessary to apply a correction factor
on these variables. Accordingly, applying the conversion
factors on the lipid concentrations did not change any of
the conclusions in the study.
In the population-based sample, the pubertal develop-
mental stage was self-evaluated with picture pattern
recognition due to practical considerations. Thus, this
method of determining puberty might be less accurate
than the same evaluation done by a trained pediatrician;
however, self-evaluated puberty distinguishing between
the pre-pubertal and pubertal stage has been shown to
be reliable in epidemiological studies [26]. The effects of
puberty on lipid concentrations did not differ from the
effects of age in our cohorts. Thus, we consider age to
be the most straightforward way to define references for
fasting plasma lipid concentrations in Danish/North-
European children and adolescents. The references de-
fined by the present study are presented both as charts
easy to use for the clinicians plotting the values of their
patients and monitoring progressions, and in tables for
integration into electronic laboratory systems.
The primary strength of the study was a large co-
hort of healthy Danish children recruited from
schools, public dentists, and healthcare nurses in 11
municipalities in Denmark, with an extensive pheno-
type collected alongside biochemical markers. In
addition, the TCOC cohort, a cohort of children and
adolescents with overweight/obesity, was collected
during the same period of time and provided infor-
mation on the effects of obesity on the lipid concen-
trations, elucidating the health-related impact obesity
has on human metabolism at an early age.
Conclusion
This study provides reference values for fasting plasma
lipid concentrations for both sexes in the age range
6 − 19 years in Danish/North-European whites. Different
patterns for girls and boys were observed for lipid con-
centrations throughout childhood and adolescence.
Furthermore, the study evaluates the effects of obesity
on lipid concentrations in childhood including an in-
creased risk of dyslipidemia, which might predispose the
children with obesity to premature CVD morbidity and
mortality later in life.
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